Regional citrate anticoagulation versus LMWH anticoagulation for CRRT in liver failure patients without increased bleeding risk

Background: The optimal anticoagulation regimen for continuous renal replacement therapy (CRRT) in liver failure (LF) patients without increased bleeding risk remains controversial. Therefore, we conducted a monocentric retrospective study to evaluate the efficacy and safety of the regional citrate...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of artificial organs 2024-10, Vol.47 (10), p.756-764
Hauptverfasser:	Tang, Siyan, Yu, Yan, Tang, Siwei, Liu, Tong, Wu, Hao, Liu, Yi, Zhao, Lijuan, Lu, Rui, Zhang, Peng, Bai, Ming
Format:	Artikel
Sprache:	eng
Schlagworte:	Accumulation Adult Aged Anticoagulants Anticoagulants - administration & dosage Anticoagulants - adverse effects Anticoagulants - therapeutic use Bleeding Citric acid Citric Acid - adverse effects Citric Acid - therapeutic use Continuous Renal Replacement Therapy - adverse effects Continuous Renal Replacement Therapy - methods Female Health risks Hemorrhage - chemically induced Heparin Heparin, Low-Molecular-Weight - adverse effects Heparin, Low-Molecular-Weight - therapeutic use Humans Life span Liver Liver Failure - mortality Liver Failure - therapy Low molecular weights Male Middle Aged Molecular weight Mortality Mortality risk Patients Regression models Renal failure Retrospective Studies Risk Risk Factors Survival Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!